INS and Hypoglycemia: In fact, even when taking into account that individuals using sulfonylurea, meglitinides, or insulin may target less stringent HbA1c levels because of risk of hypoglycemia, most individuals treated with oral polytherapy or with insulin had HbA1c levels > 7.0%.